Mostrando las entradas con la etiqueta American Psychiatric Association. Mostrar todas las entradas
Mostrando las entradas con la etiqueta American Psychiatric Association. Mostrar todas las entradas

12 mayo, 2013

Medicine's big new battleground: does mental illness really exist?

Published by the American Psychiatric Associat...
Published by the American Psychiatric Association, the DSM-IV-TR provides a common language and standard criteria for the classification of mental disorders. (Photo credit: Wikipedia)
Source: http://www.guardian.co.uk/
The latest edition of DSM, the influential American dictionary of psychiatry, says that shyness in children, depression after bereavement, even internet addiction can be classified as mental disorders. It has provoked a professional backlash, with some questioning the alleged role of vested interests in diagnosis.
It has the distinctly uncatchy, abbreviated title DSM-5, and is known to no one outside the world of mental health.
But, even before its publication a week on Wednesday, the fifth edition of the Diagnostic and Statistical Manual, psychiatry's dictionary of disorders, has triggered a bitter row that stretches across the Atlantic and has fuelled a profound debate about how modern society should treat mental disturbance.
Critics claim that the American Psychiatric Association's increasingly voluminous manual will see millions of people unnecessarily categorised as having psychiatric disorders. For example, shyness in children, temper tantrums and depression following the death of a loved one could become medical problems, treatable with drugs. So could internet addiction.
Inevitably such claims have given ammunition to psychiatry's critics, who believe that many of the conditions are simply inventions dreamed up for the benefit of pharmaceutical giants.
A disturbing picture emerges of mutual vested interests, of a psychiatric industry in cahoots with big pharma. As the writer, Jon Ronson, only half-joked in a recent TED talk: "Is it possible that the psychiatric profession has a strong desire to label things that are essential human behaviour as a disorder?"
Psychiatry's supporters retort that such suggestions are clumsy, misguided and unhelpful, and complain that the much-hyped publication of the manual has become an excuse to reheat tired arguments to attack their profession.
But even psychiatry's defenders acknowledge that the manual has its problems. Allen Frances, a professor of psychiatry and the chair of the DSM-4 committee, used his blog to attack the production of the new manual as "secretive, closed and sloppy", and claimed that it "includes new diagnoses and reductions in thresholds for old ones that expand the already stretched boundaries of psychiatry and threaten to turn diagnostic inflation into hyperinflation".
Others in the mental health field have gone even further in their criticism. Thomas R Insel, director of the National Institute of Mental Health, the American government's leading agency on mental illness research and prevention, recently attacked the manual's "validity".
And now, in a significant new attack, the very nature of disorders identified by psychiatry has been thrown into question. In an unprecedented move for a professional body, the Division of Clinical Psychology (DCP), which represents more than 10,000 practitioners and is part of the distinguished British Psychological Society, will tomorrow publish a statement calling for the abandonment of psychiatric diagnosis and the development of alternatives which do not use the language of "illness" or "disorder".
The statement claims: "Psychiatric diagnosis is often presented as an objective statement of fact, but is, in essence, a clinical judgment based on observation and interpretation of behaviour and self-report, and thus subject to variation and bias."
The language may be arcane, but the implication is clear. According to the DCP, "diagnoses such as schizophrenia, bipolar disorder, personality disorder, attention deficit hyperactivity disorder, conduct disorders and so on" are of "limited reliability and questionable validity".
Diagnosis is often described as the holy grail of psychiatry. Without it, psychiatry's foundations crumble. For this reason Mary Boyle, emeritus professor at the Univerity of East London, believes that the impact of the DCP's statement marks a dramatic shift in the mental health debate.
"The statement isn't just an account of the many problems of psychiatric diagnosis and the lack of evidence to support it," she said. "It's a call for a completely different way of thinking about mental health problems, away from the idea that they are illnesses with primarily biological causes."
Psychiatrists say that such claims have been made many times before and ignore mountains of peer-reviewed papers about the importance that biological factors play in determining mental health, including significant work in the field of genetics. It also, they say, misrepresents psychiatry's position by ignoring its emphasis on the impact of the social environment on mental health.
Most psychiatrists concede that diagnosis of psychiatric disorder is not perfect. But, as Harold S Koplewicz, a leading child and adolescent psychiatrist, explained in an article for the Huffington Post, "those lists of behaviours in the DSM, and other rating scales we use, are tools to help us look at behaviour as objectively as possible, to find the patterns and connections that can lead to better understanding and treatment".
Independent experts also say that it is hard to see how the world of mental health could function without diagnosis. "We know that, for many people affected by a mental health problem, receiving a diagnosis enabled by diagnostic documents like the DSM-5 can be extremely helpful," said Paul Farmer, chief executive of the mental health charity Mind. "A diagnosis can provide people with appropriate treatments, and could give the person access to other support and services, including benefits."
But even Farmer acknowledged that diagnosis is imperfect. "For example it takes, on average, 10 years before a person with bipolar disorder gets a correct diagnosis, which comes with a number of mental and physical health implications, such as side-effects from the wrong medication," he said.
But now the DCP has transformed the debate about diagnosis by claiming that it is not only unscientific but unhelpful and unnecessary.
"Strange though it may sound, you do not need a diagnosis to treat people with mental health problems," said Dr Lucy Johnstone, a consultant clinical psychologist who helped to draw up the DCP's statement.
"We are not denying that these people are very distressed and in need of help. However, there is no evidence that these experiences are best understood as illnesses with biological causes. On the contrary, there is now overwhelming evidence that people break down as a result of a complex mix of social and psychological circumstances – bereavement and loss, poverty and discrimination, trauma and abuse."
Eleanor Longden, who hears voices and was told she was a schizophrenic who would be better off having cancer as "it would be easier to cure", explains that her breakthrough came after a meeting with a psychiatrist who asked her to tell him a bit about herself. In a paper for the academic journal, Psychosis, Longden recalled: "I just looked at him and said 'I'm Eleanor, and I'm a schizophrenic'."
Longden writes: "And in his quiet, Irish voice he said something very powerful, 'I don't want to know what other people have told you about yourself, I want to know about you.'
"It was the first time that I had been given the chance to see myself as a person with a life story, not as a genetically determined schizophrenic with aberrant brain chemicals and biological flaws and deficiencies that were beyond my power to heal."
Longden, who is pursuing a career in academia and is now a campaigner against diagnosis, views this conversation as a crucial first step in the healing process that took her off medication. "I am proud to be a voice-hearer," she writes. "It is an incredibly special and unique experience."
Hers is an inspirational story. But to focus on one person's experiences would be to ignore the testimonies of others who believe that their mental distress has biomedical roots. Indeed, many people report that they can see no clear reason for their distress and firmly believe their life stories have little bearing on their mental state.
Nevertheless the DCP believes the world of mental health treatment would benefit from a "paradigm shift" so that it focused less on the biological aspects of mental health and more on the personal and the social.
"In essence, instead of asking 'What is wrong with you?', we need to ask 'What has happened to you?'," Johnstone said. "Once we know that, we can draw on psychological evidence to show how life events and the sense that people make of them have led to the current difficulties."
A shift away from a biological focus would give succour to psychiatry's critics, who question society's reliance on the use of drugs or interventions such as electroconvulsive therapy to treat psychiatric breakdown.
Prescriptions of antidepressants increased nearly 30% in England between 2008 and 2011, the latest available data.
A recent article in the online edition of the British Medical Journal suggested "that only one in seven people actually benefits" from antidepressants and claimed that three-quarters of the experts who wrote the definitions of mental illness had links to drug companies.
Professor Sir Simon Wessely, chair of Psychological Medicine at King's College London (KCL), argues that his profession has always emphasised the need to "look at the whole person, and indeed beyond the person to their family, and to society", and that claims psychiatry is being "taken over by the biologists" are unfounded.
This defence, which will be outlined at a major international conference on the impact of DSM-5, to be held at KCL at the beginning of June, is often lost in a shrill debate.
Indeed, it is noticeable just how vocal psychiatry's critics are becoming ahead of the publication of DSM-5. In an attempt to pour oil on troubled waters, Professor Sue Bailey, president of the Royal College of Psychiatrists, conceded that "many of the criticisms that are levelled at DSM" were valid but warned that the row was "distracting us from the real challenge, which is providing high-quality mental health services and treatment to patients and carers".
Bailey insisted the manual's publication "won't have any direct influence on the diagnosis of mental illness in the NHS". But it will frame the wider debate about how people see mental health. As Wessely acknowledged, psychiatry's critics will seize on the manual's "daft" new categories of mental disorder to bolster claims that the profession is "medicalising normality".
There is an irony here. Psychiatry lies wounded and much of the damage appears to be self-inflicted. The emotional scars may take decades to heal.

How the Diagnostic and Statistical Manual of Mental Disorders is changing


IN THE NEW MANUAL, DSM-5:
■ Disruptive mood dysregulation disorder, or DMDD, for those diagnosed with abnormally severe and frequent temper tantrums.
■ Binge-eating disorder. For those who eat to excess 12 times in three months.
■ Hoarding disorder, defined as "persistent difficulty discarding or parting with possessions, regardless of actual value".
■ Oppositional defiant disorder, described by one critic as a condition afflicting children who say "no" to their parents more than a certain number of times.
OUT OF THE MANUAL
The term "gender identity disorder", for children and adults who strongly believe they were born the wrong gender, is being replaced with "gender dysphoria" to remove the stigma attached to the word "disorder". Experts liken the switch to the removal of homosexuality as a disorder in the 1973 edition.
AND THE FUTURE?
Hypersexuality and internet addiction will both be included in a section that suggests they could become disorders following further research.
Enhanced by Zemanta

09 mayo, 2013

Parental Alienation Not A Mental Disorder, American Psychiatric Association Says

Published by the American Psychiatric Associat...
Published by the American Psychiatric Association, the DSM-IV-TR provides a common language and standard criteria for the classification of mental disorders. (Photo credit: Wikipedia)
 Source: Hufftingtong Post
Rebuffing an intensive lobbying campaign, a task force of the American Psychiatric Association has decided not to list the disputed concept of parental alienation in the updated edition of its catalog of mental disorders.
The term conveys how a child's relationship with one estranged parent can be poisoned by the other parent, and there's broad agreement that it sometimes occurs in the context of divorces and child-custody disputes.
However, an acrimonious debate has raged for years over whether the phenomenon should be formally classified as a mental health disorder by the psychiatric association as it updates its Diagnostic and Statistical Manual of Mental Disorders for the first time since 1994.
The new manual, known as DSM-5, won't be completed until next year, but the decision against classifying parental alienation as a disorder or syndrome has been made.
"The bottom line – it is not a disorder within one individual," said Dr. Darrel Regier, vice chair of the task force drafting the manual. "It's a relationship problem – parent-child or parent-parent. Relationship problems per se are not mental disorders."
Regier and his APA colleagues have come under intense pressure from individuals and groups who believe parental alienation is a serious mental condition that should be formally recognized in the DSM-5. They say this step would lead to fairer outcomes in family courts and enable more children of divorce to get treatment so they could reconcile with an estranged parent.
Among those on the other side of the debate, which has flared since the 1980s, are feminists and advocates for battered women who consider "parental alienation syndrome" to be an unproven and potentially dangerous concept useful to men trying to deflect attention from their abusive behavior.
Some critics of the concept say it's being promoted by psychologists, consultants and others who could profit if parental alienation had a more formal status in family court disputes.
"At its worst, it lines the pockets of both attorneys and expert witnesses by increasing the number of billable hours in a given case," wrote Dr. Timothy Houchin, a University of Kentucky psychiatrist, and three colleagues in an article earlier this year in the Journal of the American Academy of Psychiatry and the Law.
"It creates an entire new level of debate, in which only qualified experts can engage, adding to the already murky waters of divorce testimony," they wrote, arguing that courts could deal with parent/child estrangement without labeling the child as mentally ill.
Advocates of the concept of parental alienation had been braced for a decision by the APA not to classify it as a syndrome or disorder, but held out hope that it would be specifically cited in an appendix as an example of a parent-child relational problem.
Regier, in an e-mail Friday, said this is "very unlikely," even though the final draft of the DSM-5 remains incomplete.
Dr. William Bernet, a professor emeritus of psychiatry at the Vanderbilt University School of Medicine, is editor of a 2010 book making the case that parental alienation should be recognized in the DSM-5. He contends that about 200,000 children in the U.S. are affected by the condition.
Bernet's proposal to the DSM-5 task force defines parental alienation disorder as "a mental condition in which a child, usually one whose parents are engaged in a high conflict divorce, allies himself or herself strongly with one parent, and rejects a relationship with the other parent, without legitimate justification."
In a telephone interview, Bernet contended that the task force had made up its mind based on factors beyond the scientific evidence.
"I think they're being motivated not by the science, but being driven by friendships, by political forces," he said.
Parental alienation surfaced on the pop-culture scene several years ago as a consequence of the bitter divorce and child custody battle involving actors Alec Baldwin and Kim Basinger. Baldwin was assailed by some feminist groups for citing parental alienation syndrome as a source of his estrangement from his daughter.
"The truth is that parental alienation really is a dangerous and cleverly marketed legal strategy that has caused much harm to victims of abuse," said the National Organization for Women amid the controversy.
Bernet, in his proposal to the DSM-5 task force, said he agreed that "in some instances the concept of parental alienation has been misused by abusive parents to hide their behavior."
"However, we strongly disagree with throwing out the baby with the bathwater," he wrote, arguing that such abuse would be curtailed if diagnostic criteria for parental alienation were established.

Comments from facebook:

David Charles Avi Leidner The debate has raised massive levels of casualties. From extremes of publicity; such as the stupefaction of Civil Rights advocates faced with the daunting media specter of a spectacularly publicized pop star medicalization becoming staging grounds for legally sanctioned indefinite (temporary) dispossession of all private earnings and personal assets being delivered to the conservatorship control of alienated parents -

To extremes of "Privacy," contributing to the collapse of entire institutions such as the ironically named former Thalians Psychiatric Hospital, which had championed the pathologizing of Parental Alienation as a mental [dis]order, which without DSM-V, DSM-aVI, or Star Trek DS-9 recognition, is forced to labor under the hefty label of Psychosis NOS r/o BiPolar.

This is especially paradoxical in light of the Thalians' citing economic failure during an era of a psychiatric medicalization boom as the cause of its closing.

The closure was, incidentally not related to any failure to conform records to meet with government criteria for evidence based medical reporting which it's parent Medical Group was eager to adopt early on. Nor was the divorce of the Thalians from its Parent Madical Group over matters of Parental Alienation.

An undisclosed source, related to the issue was quoted as stating, "The fact remains that the world requires that we communicate succinctly -- and accurately -- if we wish to be heard, understood and sometimes, helped." Experts remain baffled pertaining to his qualification to speak on behalf of The World, despite The World having no apparent comment on the matter.
Enhanced by Zemanta

07 mayo, 2013

National Institute of Mental Health abandoning the DSM

Source: http://mindhacks.com

In a potentially seismic move, the National Institute of Mental Health – the world’s biggest mental health research funder, has announced only two weeks before the launch of the DSM-5 diagnostic manual that it will be “re-orienting its research away from DSM categories”.
In the announcement, NIMH Director Thomas Insel says the DSM lacks validity and that “patients with mental disorders deserve better”.
This is something that will make very uncomfortable reading for the American Psychiatric Association as they trumpet what they claim is the ‘future of psychiatric diagnosis’ only two weeks before it hits the shelves.
As a result the NIMH will now be preferentially funding research that does not stick to DSM categories:

Going forward, we will be supporting research projects that look across current categories – or sub-divide current categories – to begin to develop a better system. What does this mean for applicants? Clinical trials might study all patients in a mood clinic rather than those meeting strict major depressive disorder criteria. Studies of biomarkers for “depression” might begin by looking across many disorders with anhedonia or emotional appraisal bias or psychomotor retardation to understand the circuitry underlying these symptoms. What does this mean for patients? We are committed to new and better treatments, but we feel this will only happen by developing a more precise diagnostic system.
As an alternative approach, Insel suggests the Research Domain Criteria (RDoC) project, which aims to uncover what it sees as the ‘component parts’ of psychological dysregulation by understanding difficulties in terms of cognitive, neural and genetic differences.
For example, difficulties with regulating the arousal system might be equally as involved in generating anxiety in PTSD as generating manic states in bipolar disorder.
Of course, this ‘component part’ approach is already a large part of mental health research but the RDoC project aims to combine this into a system that allows these to be mapped out and integrated.
It’s worth saying that this won’t be changing how psychiatrists treat their patients any time soon. DSM-style disorders will still be the order of the day, not least because a great deal of the evidence for the effectiveness of medication is based on giving people standard diagnoses.
It is also true to say that RDoC is currently little more than a plan at the moment – a bit like the Mars mission: you can see how it would be feasible but actually getting there seems a long way off. In fact, until now, the RDoC project has largely been considered to be an experimental project in thinking up alternative approaches.
The project was partly thought to be radical because it has many similarities to the approach taken by scientific critics of mainstream psychiatry who have argued for a symptom-based approach to understanding mental health difficulties that has often been rejected by the ‘diagnoses represent distinct diseases’ camp.
The NIMH has often been one of the most staunch supporters of the latter view, so the fact that it has put the RDoC front and centre is not only a slap in the face for the American Psychiatric Association and the DSM, it also heralds a massive change in how we might think of mental disorders in decades to come.
 

Link to NIMH announcement ‘Transforming Diagnosis’.
Enhanced by Zemanta

23 abril, 2012

Legal Drug-Pushing: How Disease Mongers Keep Us All Doped Up


Fuente: DISMONG
Via: Juan Gérvas

By manipulating our fear of suffering and death, big pharmaceutical companies are able to keep us coming back for expensive medications.
Paul Matthew Photography/Shutterstock
Pharmaceutical giants, like small-town pizza parlors, have two options for making more money: convince regulars to buy more of what they obviously like, or find ways to persuade more people that they will be happier with this drug or that thin crust with extra cheese.
In the case of the drug companies, it's not our taste buds they're appealing to. Instead, they market prescription drugs directly to consumers -- a practice legal only in the United States and New Zealand -- by, basically, manipulating our fear of suffering and death.
These "disease mongers" -- as science writer Lynne Payer in her 1992 book of that name called the drug industry and the doctors, insurers, and others who comprise its unofficial sales force -- spin and toil "to convince essentially well people that they are sick, or slightly sick people that they are very ill."
Changing the metrics for diagnosing a disease is one reliable technique. Dr. Adriane Fugh-Berman, associate professor of pharmacology and director of the industry watchdog group PharmedOut.org at Georgetown University School of Medicine, pointed to how the numbers used to diagnose diabetes and high cholesterol have been lowered over time. "The very numbers we use have been reduced to the point of absurdity," she said. "120/80 was considered normal blood pressure; now it's considered 'pre-hypertension.'"
Entirely new diseases can be, and have been, invented to extend a manufacturer's patent on a highly profitable drug. Fugh-Berman said Eli Lilly stood to lose a lot of profits once the patent expired on its hugely popular antidepressant Prozac. "So they positioned this new condition, PMDD (Pre-Menstrual Dysphoric Disorder), and then went to physicians and the FDA with their highly paid experts who said PMDD is a tragic disease, and they got approved for Sarafem, the same drug. It's an on-label use for a repackaged drug; they created the disease and then got a drug re-approved that was going off patent."
Just how sly a move was it? "If I as a physician write a prescription for Prozac 20 mg," Fugh-Berman said, "the pharmacist can substitute fluoxetine, the generic. If I write a prescription for Serafem, they can't substitute another drug."
A TEXTBOOK CASE
Dr. Leonore Tiefer, a noted sexologist and associate clinical professor of psychiatry at New York University School of Medicine, said the 1998 approval of Viagra for "erectile dysfunction" -- formerly known as impotence -- created a "sea change" in the field of urology. "It was like being sucked into a very medical model and treatment orientation," she told me.
People immediately started asking about Viagra for women. As it was doing for men, Tiefer said that, as a feminist, writing about women, "I knew what would happen if there was a Viagra for women -- the isolation of the function from the person, the isolation of the genitalia from the rest of the body."
The only way to redefine "what a woman wants" -- and build a case for a drug to "treat" it -- was to turn "it" into a medical condition. Without widespread agreement on its definition, pathophysiology, or clinical manifestations, Female Sexual Dysfunction (FSD) was created. Tiefer called the development of FSD "a textbook case of disease mongering by the pharmaceutical industry and by other agents of medicalization."
With Pfizer's 2011 U.S. Viagra sales pushing $2 billion, and Eli Lilly's Cialis catching up, the booming "enhancement" market suggests that either there has been an extraordinary uptick in male impotence -- or that Pharma has convinced multitudes of men that erectile dysfunction, "E.D." for short, has reached epidemic proportions (40 percent of men are allegedly "at risk"), and drugs are the only solution.
It pains to think of the men who aren't ready when the moment is right as a result of taking Propecia to "treat" another natural effect of aging nearly as widespread among men as occasionally uncooperative equipment: male pattern baldness, or, in medicalese, alopecia.
The fact is you may not need chemical enhancement for the E.D. or the baldness. The best remedy for both may be to reexamine your beliefs about why hair or hardness are so important. A shot of redefined meanings can do wonders to restore normal functioning.
THE MEDICAL INDUSTRIAL COMPLEX
Australia-based journalist and disease-mongering researcher Ray Moynihan, author of Selling Sickness, said in an email, "We seem to be living through the most extraordinary paradox: We have never been healthier, yet we seem to consider ourselves sicker and sicker than ever. Mild symptoms, inconvenience, being at low-risk, aging, human life, and death, are rapidly being medicalized."
No other medical specialty has turned more aspects of human life into diagnoses than psychiatry. Not coincidentally, no other medical specialty shares a cozier relationship with the pharmaceutical industry -- its resources flowing lavishly through conference and continuing medical education (CME) funding, medical research support, and generous contributions to patient advocacy groups happy for the donations and glad to endorse a drug if it will help others.
Dr. Marcia Angell, the editor of the New England Journal of Medicine for more than 20 years, in a two-part 2011 essay in the New York Review of Books singled out psychiatry for its "subjective and expandable" diagnostic categories. She noted that in the fifth edition of the American Psychiatric Association's Diagnostic and Statistical Manual (DSM-V), to be published in 2013, "diagnostic boundaries will be broadened to include even precursors of disorders, such as 'psychosis risk syndrome' and 'mild cognitive impairment' (possibly early Alzheimer's disease)."
As Angell said, "It looks as though it will be harder and harder to be normal."
ARE YOU BEING OVERDIAGNOSED?
Two doctors, a husband and wife team, both medical professors at the Dartmouth Institute for Health Policy and Clinical Practice, have warned for years in major medical journals that direct-to-consumer advertisements of prescription drugs have created an overly medicalized and over-drugged culture.
Dr. Steven Woloshin and Dr. Lisa M. Schwartz, co-authors of Know Your Chances and Overdiagnosed: Making People Sick in the Pursuit of Health, said in an interview that people need to know about a drug's potential benefits and harms -- in detail. "People need to ask, what is this going to do for me?" Schwartz said. "How likely is it that taking this drug will help me, and by how much? And what are the side-effects? How likely are they? Are they dangerous? Bothersome?"
Woloshin said consumers deserve to know, as specifically as possible, what clinical trials have revealed about a drug. "What percentage of people taking this cholesterol medication had a heart attack vs. the percentage who had a heart attack taking placebo. That's what you want to look for: What is my chance of having a good or bad thing come from taking the drug?"
Woloshin and Schwartz have long advocated for the FDA to require drug facts boxes for prescription drugs: short summaries of benefits and side-effects inspired by the nutrition facts boxes on food packaging. In a July 4, 2011, commentary in The New York Times, the pair noted, "The only way to truly know a drug's benefit is by seeing data from randomized clinical trials of people, data that may be very hard to find."
Otherwise, Woloshin explained, the manufacturer "may exaggerate. For example, just present what is found in the drug group and not the placebo group. It's to make the benefit seem big by saying 'twice as many' improved on the drug when in fact only two percent improved with the drug vs. one percent with placebo."
WHAT'S A BODY TO DO?
"Sadly," Ray Moynihan said, "it is very difficult to work out what is valuable information and what is misleading marketing disguised as news or scientific information -- particularly on television, but also in other media, including, of course, the Net." He recommends finding "reliable independent sources and go[ing] to them when you need to." He suggested the Cochrane Systematic Reviews and Consumer Reports, and the Therapeutics Initiative in Canada as good choices.
"Follow the money," advises PharmedOut.org director Fugh-Berman. "You want to trust sources of information that aren't industry paid." She recommends seeking information from advocacy organizations, media, and other sources that don't take drug money. "If you look at what these groups are saying about therapies and treatments and compare it to what groups that are taking money from pharmaceutical companies are saying, they're different," she said.
Some reformers call for government regulators to prohibit all direct-to-consumer advertising of prescription drugs. Others see the need for multiple parties to accept their role in resisting the disease mongers. "I think the responsibilities are distributed equally and include those contributing to the culture of society -- artists; writers, including journalists; film makers; etc.," said Dr. Iona Heath, president of the Royal College of General Practitioners, in London, via email. In a follow-up, she added, "I don't want to be seen to be offloading the medical responsibility for putting our own house in order in relation to pharma funding for both research and education. I also deplore DTCA."
A leading critic of disease mongering, Heath believes doctors must stop accepting pharmaceutical money for things like conferences, continuing medical education, and speaking engagements. But simply swearing off Pharma support won't solve the problem of overdiagnosis and the corresponding overprescription of drugs.
Heath said in her Harveian Oration, delivered to the Royal College of Physicians on October 18, 2011, that the root of the problem -- the reason disease mongering works -- is the mind-body split in medicine. She said doctors need to be students of what she calls "the biology of biography" -- the impact on health of trauma, poverty, racism, violence, and the hurtful things human beings do to one another. "When symptoms rooted in a traumatic and damaging biography are treated as biotechnical problems," she said, "medicine has an alarming tendency to cause more harm than good."
Many of us don't get to "the causes of the causes" of our illnesses and malfunctions. We learn to adjust and accommodate. Others of us learn to attach different meanings to the medical labels imposed on us so that we can live in relative peace with what may be a stigmatizing diagnosis.
Still others are content simply to medicate what may well be the symptom of an underlying condition. Out of sight, out of mind. Exactly as the disease mongers need it to be.


Enhanced by Zemanta